BAYER AG
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to Mapracorat
- First Posted Date
- 2018-01-16
- Last Posted Date
- 2018-01-16
- Lead Sponsor
- Bayer
- Target Recruit Count
- 24
- Registration Number
- NCT03399526
A Pharmacokinetic Trial of Naproxen Sodium and Diphenhydramine Hydrochloride Soft Capsules Versus Naproxen Sodium and Diphenhydramine Hydrochloride Tablets in Healthy Adult Subjects
- Conditions
- Pain
- Interventions
- First Posted Date
- 2018-01-10
- Last Posted Date
- 2019-03-20
- Lead Sponsor
- Bayer
- Target Recruit Count
- 36
- Registration Number
- NCT03396250
- Locations
- 🇺🇸
ICON Development Solutions, LLC, San Antonio, Texas, United States
Metastatic Colorectal Cancer Patients With Long-term Response to Regorafenib
- First Posted Date
- 2017-12-29
- Last Posted Date
- 2018-05-15
- Lead Sponsor
- Bayer
- Target Recruit Count
- 76
- Registration Number
- NCT03386825
- Locations
- 🇧🇪
Belgium, Multiple Locations, Belgium
Observational Study to Assess Intravitreal Aflibercept Injections Used in a "Treat and Extend" Regimen in Treatment-naïve Wet Age-related Macular Degeneration Patients
- Conditions
- Wet Age-related Macular Degeneration
- Interventions
- First Posted Date
- 2017-12-26
- Last Posted Date
- 2023-06-05
- Lead Sponsor
- Bayer
- Target Recruit Count
- 163
- Registration Number
- NCT03382587
- Locations
- 🇨🇭
Many Locations, Multiple Locations, Switzerland
Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients
- Conditions
- Nonvalvular Atrial Fibrillation
- Interventions
- First Posted Date
- 2017-12-15
- Last Posted Date
- 2020-08-17
- Lead Sponsor
- Bayer
- Target Recruit Count
- 78517
- Registration Number
- NCT03374540
- Locations
- 🇺🇸
Truven Health MarketScan Commercial Claims and Medicare Supplemental Databases, Multiple Locations, Washington, United States
A Study to Test Whether Study Drug BAY1128688 Brings Pain Relief to Women With Endometriosis and if so to Get a First Idea Which Dose(s) Work Best
- Conditions
- Endometriosis
- Interventions
- Drug: BAY1128688Drug: Placebo
- First Posted Date
- 2017-12-14
- Last Posted Date
- 2019-10-03
- Lead Sponsor
- Bayer
- Target Recruit Count
- 121
- Registration Number
- NCT03373422
- Locations
- 🇦🇹
Kepler Universitätsklinikum, Linz, Oberösterreich, Austria
🇦🇹Medizinische Universität Graz, Graz, Steiermark, Austria
🇦🇹Landeskrankenhaus - Universitätskliniken Innsbruck, Innsbruck, Austria
BAY94-9027 PK Study Comparing to Another Long Acting Product
- First Posted Date
- 2017-12-07
- Last Posted Date
- 2019-09-09
- Lead Sponsor
- Bayer
- Target Recruit Count
- 18
- Registration Number
- NCT03364998
- Locations
- 🇧🇬
SHATHD Spec. Hospi. for Active Treatm. of Haematol. Dis. EAD, Sofia, Bulgaria
Clinical Outcomes Among Non-valvular Atrial Fibrillation Patients With Renal Dysfunction
- Conditions
- Atrial Fibrillation
- Interventions
- First Posted Date
- 2017-12-02
- Last Posted Date
- 2019-12-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 16000
- Registration Number
- NCT03359876
- Locations
- 🇺🇸
US Truven MarketScan, Whippany, New Jersey, United States
Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam
- Conditions
- Biological Availability
- Interventions
- Drug: Desogestrel/ CerazetteDrug: Norethindrone/ NoridayDrug: levonorgestrel/ MicrolutDrug: Dienogest/ VisanneDrug: Drospirenone, Ethinylestradiol/ YasminDrug: Midazolam/ Midazolam-ratiopharmDrug: Rifampicin
- First Posted Date
- 2017-11-27
- Last Posted Date
- 2020-04-15
- Lead Sponsor
- Bayer
- Target Recruit Count
- 68
- Registration Number
- NCT03353857
- Locations
- 🇩🇪
CRS Clinical-Research-Services Mannheim GmbH, Mannheim, Baden-Württemberg, Germany
🇩🇪CRS Clinical-Research-Services Mönchengladbach GmbH, Mönchengladbach, Nordrhein-Westfalen, Germany
A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects
- Conditions
- AnemiaRenal Insufficiency, Chronic
- Interventions
- First Posted Date
- 2017-11-22
- Last Posted Date
- 2021-01-29
- Lead Sponsor
- Bayer
- Target Recruit Count
- 162
- Registration Number
- NCT03350321
- Locations
- 🇯🇵
Steel Memorial Yawata Hospital, Kitakyushu, Fukuoka, Japan
🇯🇵St.Mary's Hospital, Kurume, Fukuoka, Japan
🇯🇵Kokura Memorial Hospital, Kitakyushu, Fukuoka, Japan